Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Connie Celum

Showing results (1-10 of 377) with videos related to

Pageof 38
Sort By:
The Lancet. Infectious Diseases|June 1, 2022
Sexually transmissible infection incidence in men who have sex with men using HIV pre-exposure prophylaxis in AustraliaChase Cannon, Connie Celum
Annual Review of Medicine|October 2, 2012
Systemic and topical drugs for the prevention of HIV infection: antiretroviral pre-exposure prophylaxisJared Baeten, Connie Celum
Cell Host & Microbe|April 10, 2020
PrEP for HIV Prevention: Evidence, Global Scale-up, and Emerging OptionsConnie Celum, Jared Baeten
Current Opinion in HIV and AIDS|September 12, 2012
Oral antiretroviral chemoprophylaxis: current statusJared Baeten, Connie Celum
The Lancet. HIV|December 26, 2018
Reaching the 90-90-90 target: lessons from HIV self-testingConnie Celum, Ruanne Barnabas
The Lancet. HIV|October 2, 2015
The changing virulence of HIVJoshua Herbeck, Connie Celum
Current Opinion in Infectious Diseases|December 14, 2011
Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidenceConnie Celum, Jared M Baeten
Drugs|February 8, 2007
Clinical and therapeutic issues for herpes simplex virus-2 and HIV co-infectionJairam R Lingappa, Connie Celum
Lancet (London, England)|July 22, 2014
Bending the curve: maximising impact with focused HIV preventionRuanne V Barnabas, Connie Celum
The New England Journal of Medicine|January 8, 2013
Antiretroviral preexposure prophylaxis for HIV preventionJared M Baeten, Connie Celum
Pageof 38

Showing results (1-10 of 377) with videos related to

Sort By:
Pageof 38
The Lancet. Infectious Diseases|June 1, 2022
Sexually transmissible infection incidence in men who have sex with men using HIV pre-exposure prophylaxis in AustraliaChase Cannon, Connie Celum
Annual Review of Medicine|October 2, 2012
Systemic and topical drugs for the prevention of HIV infection: antiretroviral pre-exposure prophylaxisJared Baeten, Connie Celum
Cell Host & Microbe|April 10, 2020
PrEP for HIV Prevention: Evidence, Global Scale-up, and Emerging OptionsConnie Celum, Jared Baeten
Current Opinion in HIV and AIDS|September 12, 2012
Oral antiretroviral chemoprophylaxis: current statusJared Baeten, Connie Celum
The Lancet. HIV|December 26, 2018
Reaching the 90-90-90 target: lessons from HIV self-testingConnie Celum, Ruanne Barnabas
The Lancet. HIV|October 2, 2015
The changing virulence of HIVJoshua Herbeck, Connie Celum
Current Opinion in Infectious Diseases|December 14, 2011
Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidenceConnie Celum, Jared M Baeten
Drugs|February 8, 2007
Clinical and therapeutic issues for herpes simplex virus-2 and HIV co-infectionJairam R Lingappa, Connie Celum
Lancet (London, England)|July 22, 2014
Bending the curve: maximising impact with focused HIV preventionRuanne V Barnabas, Connie Celum
The New England Journal of Medicine|January 8, 2013
Antiretroviral preexposure prophylaxis for HIV preventionJared M Baeten, Connie Celum
Pageof 38